Clinical trial · Observational
Study on Infectious Mononucleosis in Munich
Study on Biomarkers and Causative Factors of Complicated and/or Protracted Epstein-Barr Virus-associated Infectious Mononucleosis
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This observational clinical study aims at the identification of novel biomarkers and causative factors of complicated and/or protracted Epstein-Barr virus-associated infectious mononucleosis (IM). Clinical, biochemical, and routine virological data were collected from 200 patients with IM, novel analytical tools were implemented, and immunological and virological experimental data were generated using blood samples and mouthwashes. Patients have been investigated within four weeks after the onset of symptoms as well as one month and six months thereafter.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Epstein-Barr Virus Infections | — | UNRESOLVED | — |
| Infectious Mononucleosis | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Severity
- timeFrame
- Six months
- description
- Maximal severity of symptoms during the course of IM according the the IMMUC-Score.
- measure
- Complexity
- timeFrame
- Six months
- description
- Maximal complexity of symptoms during the course of IM according the the IMMUC-Score
- measure
- Protraction
- timeFrame
- Six months
- description
- Maximal protraction of symptoms during the course of IM according the the IMMUC-Score.
Secondary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 0 Years
- Maximum age
- 39 Years
Show eligibility criteria text
Inclusion Criteria: * IM onset within the last four weeks * with at least one of four typical clinical findings (tonsillopharyngitis, fever, lymphadenopathy, fatigue) - virological findings indicating primary EBV infection (EBV-specific antibodies, EBV DNA). Exclusion Criteria: * Pregnancy * transfusion * and/or transplantation during the last year * and/or no informed consent.
References
Publications (0)
Data not yet available